
Acorda Therapeutics ACOR
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Acorda Therapeutics P/S 2011-2026 | ACOR
P/S Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.142 | 0.115 | 0.0823 | 0.356 | 0.524 | 1.64 | 2.07 | 1.71 | 3.16 | 4.26 | 3.58 | 3.72 | 3.42 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.26 | 0.0823 | 1.91 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 21.77 | 1.68 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.92 | 3.05 % | $ 6.76 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.44 | 2.16 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 2.02 | 5.76 % | $ 420 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Heron Therapeutics
HRTX
|
1.28 | $ 1.26 | 6.3 % | $ 210 M | ||
|
ImmuCell Corporation
ICCC
|
2.1 | $ 8.28 | -0.84 % | $ 74.7 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 103.31 | -2.04 % | $ 27.2 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.14 | 1.47 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.57 | 1.33 % | $ 3 B | ||
|
Innate Pharma S.A.
IPHA
|
14.7 | $ 1.39 | 0.72 % | $ 235 M | ||
|
Inventiva S.A.
IVA
|
128 | $ 5.18 | 0.49 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
0.0831 | $ 0.36 | -8.39 % | $ 840 K | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.46 | 1.04 % | $ 389 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
KalVista Pharmaceuticals
KALV
|
17 | $ 20.08 | 2.29 % | $ 1.08 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.99 | 2.05 % | $ 4.92 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Kazia Therapeutics Limited
KZIA
|
21.9 | $ 12.42 | 1.26 % | $ 1.65 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |